BPC 157 has been demonstrated to reverse the hypertension induced in hyperkalemic rat 31
(2024) demonstrated that nitazoxanide and tizoxanide activates AMPK, inhibits STAT3 and Smad2/3 activation, collagen I expression and secretion leading to inhibition of liver fibrosis induced by carbon tetrachloride-induced and bile duct ligation in mice (Liu et al., 2024)
Moreover, many patients report sustained weight loss with continued use of GLP-1 treatments
Other participants in the investment include Supergut founding investor Dave Friedberg via The Production Board along with Cultivian Sandbox, Strand Equity, Access Capital, Alpha Edison, LivWell Ventures and Rocana Ventures
Both techniques demand specialized equipment, trained personnel and laboratory infrastructure, limiting their availability to specialized tertiary or research centers rather than routine outpatient clinics